Infant Bacterial Therapeutics AB (publ)

kr 73.60As of Sun 8 Nov 2026, 12:00 UTC
STO:IBT-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 5.30%
Div yield —
ROE (87.44%)
Biotechnology
Beta (5Y) 0.27
PE TTM —
TSR TTM 24.75%
Mkt cap kr 991.5M
ROIC (56.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 74
0.13%
(45.49%)
Hold 0|6|1|7|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.83
0.88
0.90
0.98
15.84%
19.63%
13.65%
26.75%
Revenuekr M
108.0
106.4
105.5
105.5
15.17%
10.99%
5.63%
1.05%
Peers (US$100.2M)
Cap (US$)
PE
112.2M
—
86.51M
—
85.32M
22.67x
Capital
TTM
5Y
10Y
Leveragex
1.164
0.752
0.647
EBIT/Intx
0.170
0.278
0.259
Own earn%
(40.61)
(7.37)
(9.56)
Sh yield%
29.67
24.05
24.53
Owners
Insiders/Inst%
7.60
83.81
Short interest%
3.70
SBC / revenue%
0.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
13–19
$1 testx
—
Incr. ROIC%
5